Subtopic Deep Dive

Economic Evaluations of HIV Interventions
Research Guide

What is Economic Evaluations of HIV Interventions?

Economic evaluations of HIV interventions assess cost-effectiveness, cost-benefit, and resource allocation impacts of prevention, treatment, and mitigation programs using metrics like DALYs and CBA.

Researchers apply methods such as cohort analysis from the Africa Centre Demographic Information System (Tanser et al., 2007, 418 citations) and evaluate global health initiatives' effects on systems (Biesma et al., 2009, 409 citations). Evaluations compare ARV rollout across countries in resource-limited settings. Over 10 key papers exceed 300 citations each.

Curated Papers

Key Challenges

Why It Matters

Economic evaluations guide funding prioritization for high-impact HIV interventions in low-income countries, as shown in analyses of global health initiatives' system effects (Biesma et al., 2009). They inform ARV program scaling using cohort data from South Africa (Tanser et al., 2007). Community health worker programs' cost implications for HIV responses are quantified (Schneider et al., 2008). These assessments optimize DALY reductions amid competing health burdens like TB comorbidity (Marais et al., 2013).

Key Research Challenges

Data scarcity in low-resource settings

Longitudinal HIV data is limited outside cohorts like ACDIS (Tanser et al., 2007). Cost measurements vary across countries, complicating CBA comparisons. Global initiatives distort local system costs (Biesma et al., 2009).

Heterogeneity in intervention costs

Community health worker programs face scaling tensions in South Africa (Schneider et al., 2008). ARV rollout costs differ by health system readiness (Bekker et al., 2018). Mental health integration adds unmeasured economic layers (Hanlon et al., 2014).

Long-term outcome projection

DALY estimates require modeling beyond short-term data, challenged by comorbidities like TB (Marais et al., 2013). Sustainable Development Goals demand multi-decade projections (Bekker et al., 2018). Barrier analyses overlook economic testing costs (Deblonde et al., 2010).

Essential Papers

Handbook of Research Methods in Health Social Sciences

Pranee Liamputtong · 2019 · 1.0K citations

This Handbook provides a comprehensive picture of research methods and research practices in the health and social sciences.

Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society—Lancet Commission

Linda‐Gail Bekker, George A.O. Alleyne, Stefan Baral et al. · 2018 · The Lancet · 734 citations

Cohort Profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey

Frank Tanser, Victoria Hosegood, Till Bärnighausen et al. · 2007 · International Journal of Epidemiology · 418 citations

The health and demography of the South African population has been undergoing substantial changes as a result of the rapidly progressing HIV epidemic. Researchers at the University of KwaZulu-Natal...

The effects of global health initiatives on country health systems: a review of the evidence from HIV/AIDS control

Regien Biesma, Ruairı́ Brugha, Andrew Harmer et al. · 2009 · Health Policy and Planning · 409 citations

This paper reviews country-level evidence about the impact of global health initiatives (GHIs), which have had profound effects on recipient country health systems in middle and low income countrie...

Community health workers and the response to HIV/AIDS in South Africa: tensions and prospects

Helen Schneider, Hlengiwe Isabel Hlophe, Dingie van Rensburg · 2008 · Health Policy and Planning · 354 citations

After a decline in enthusiasm for national community health worker (CHW) programmes in the 1980s, these have re-emerged globally, particularly in the context of HIV. This paper examines the case of...

Barriers to HIV testing in Europe: a systematic review

Jessika Deblonde, Petra De Koker, F F Hamers et al. · 2010 · European Journal of Public Health · 343 citations

Some barriers to HIV testing and counselling have been illustrated in the literature. Nevertheless, there is lack of structured information on barriers considering (i) legal, administrative and fin...

Challenges and Opportunities for Implementing Integrated Mental Health Care: A District Level Situation Analysis from Five Low- and Middle-Income Countries

Charlotte Hanlon, Nagendra P. Luitel, Tasneem Kathree et al. · 2014 · PLoS ONE · 329 citations

The low level of baseline health system preparedness across sites underlines that interventions at the levels of health care organisation, health facility and community will all be essential for su...

Reading Guide

Foundational Papers

Start with Tanser et al. (2007, 418 citations) for cohort data basics enabling cost tracking; Biesma et al. (2009, 409 citations) for GHI evaluation frameworks; Schneider et al. (2008, 354 citations) for CHW cost tensions.

Recent Advances

Bekker et al. (2018, 734 citations) advances SDG-aligned evaluations; Liamputtong (2019) handbook covers health social science methods for economics.

Core Methods

Cohort surveillance (Tanser et al., 2007); GHI impact reviews (Biesma et al., 2009); DALY/CBA in low-resource scaling (Bekker et al., 2018).

How PapersFlow Helps You Research Economic Evaluations of HIV Interventions

Discover & Search

Research Agent uses searchPapers and citationGraph on 'Economic Evaluations of HIV Interventions' to map 734-citation Lancet Commission (Bekker et al., 2018), revealing connections to GHIs (Biesma et al., 2009). exaSearch finds cohort-based cost studies; findSimilarPapers expands from Tanser et al. (2007).

Analyze & Verify

Analysis Agent applies readPaperContent to extract CBA metrics from Biesma et al. (2009), then verifyResponse with CoVe checks claims against Tanser et al. (2007) data. runPythonAnalysis computes DALY cost-effectiveness ratios via pandas on extracted tables; GRADE grading scores intervention evidence quality.

Synthesize & Write

Synthesis Agent detects gaps in ARV economic data across Africa using contradiction flagging on Bekker et al. (2018) vs. Schneider et al. (2008). Writing Agent employs latexEditText for methods sections, latexSyncCitations for 10+ papers, and latexCompile for full reports; exportMermaid diagrams cost-benefit flows.

Use Cases

"Run cost-effectiveness simulation for CHW HIV programs in South Africa using Schneider 2008 data."

Analysis Agent → readPaperContent (Schneider et al., 2008) → runPythonAnalysis (pandas simulation of scaling costs vs. DALYs) → matplotlib plot of ROI curves.

"Draft LaTeX report comparing GHI impacts on HIV systems from Biesma 2009."

Synthesis Agent → gap detection (Biesma et al., 2009 vs. Tanser et al., 2007) → Writing Agent → latexEditText (intro/methods) → latexSyncCitations → latexCompile (PDF with tables).

"Find code for HIV cohort economic modeling from recent papers."

Research Agent → searchPapers (HIV economic models) → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect (extracts Python CBA scripts linked to cohort data).

Automated Workflows

Deep Research workflow conducts systematic review of 50+ HIV economic papers, chaining searchPapers → citationGraph → GRADE grading for structured cost-effectiveness report. DeepScan applies 7-step analysis with CoVe checkpoints to verify ARV intervention claims from Bekker et al. (2018). Theorizer generates allocation models from literature gaps in Biesma et al. (2009).

Try Doxa for Economic Evaluations of HIV Interventions Research

Frequently Asked Questions

What is economic evaluation of HIV interventions?

It quantifies cost-effectiveness and benefits of HIV programs using DALYs, CBA, and cohort data like ACDIS (Tanser et al., 2007).

What methods are used?

CBA and DALY metrics evaluate GHIs (Biesma et al., 2009); cohort surveillance tracks ARV impacts (Tanser et al., 2007).

What are key papers?

Bekker et al. (2018, 734 citations) on SDG-era responses; Biesma et al. (2009, 409 citations) on GHI system effects; Tanser et al. (2007, 418 citations) on South African cohorts.